Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy
Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
tuberous sclerosis complex
Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex
Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory…